Latest Announcements

Aether Industries Ltd has collaborated with Dow Chemical International Pvt. Ltd. to develop new manufacturing technologies for silicones. The program will be executed at Aether's R&D and pilot facilities in Surat, Gujarat. This collaboration represents a milestone in advancing domestic innovation and has the potential for long-term commercialization and industrial-scale manufacture of technologies developed through the program.

Strides Pharma Science Ltd has announced its Q1FY27 earnings, with revenue growth of 13% YoY, and EBITDA growth of 5.4% YoY, despite a ₹131m impact on freight and operating costs from geopolitical disruptions. The company has also unlocked ₹1,000m of value through the divestment of its majority stake in Pivot Path, and improved its EcoVadis sustainability score to 68/100, a 19-point increase over last year.

OneSource Specialty Pharma Ltd has announced its Q1 FY27 earnings, with revenues at INR4,490 million, a 37% year-on-year growth, driven by the semaglutide commercial launch, new MSA contracts, and new customer wins. EBITDA has also grown 39% year-on-year and 34% sequentially.

Strides Pharma Science Ltd reported Q1FY27 results with revenue at ₹12,654m, a 13% YoY growth, driven by 17% YoY growth in Ex-US Markets. EBITDA grew 5.4% YoY to ₹2,298m, despite a ₹131m impact on operating costs from geopolitical disruptions. The company unlocked ₹1,000m of value through the divestment of its majority stake in Pivot Path, its captive GCC, while retaining meaningful participation in its future growth.

Shadowfax Technologies Ltd reported its Q1 FY27 performance, achieving record revenue, margins, and profitability. Revenue grew 64.9% YoY to ₹1,358 Cr, Adjusted EBITDA margin expanded to 4.9%, and PAT reached an all-time high of ₹65 Cr.

Aether Industries Ltd reported strong quarterly sales growth of 27% YoY and 7% QoQ, driven by 75% YoY growth in Contract and Exclusive Manufacturing (CEM) and 20% YoY growth in Contract Research and Manufacturing Services (CRAMS). The company also provided an update on its manufacturing sites, with new names and a focus on diversification across sectors.

Aether Industries Ltd has announced its Q1 FY27 financial results, with a 27% YoY growth in operating revenue to ₹3,051 M, driven by growing CEM contracts and price-led LSM demand. The company has also reported a 31% YoY growth in EBITDA to ₹814 M, and a 33% YoY growth in profit after tax to ₹540 M.

Alicon Castalloy Ltd has announced the setting up of a new manufacturing facility for GDC, LPDC, and machining with a capital outlay of Rs. 1,255 million, to be financed by borrowing and internal accruals.

Vikran Engineering Ltd has secured a ₹120.69 Crore order from Power Grid Corporation of India Ltd for the 400 kV GIS Substation Extension Package SS-147.

Bajaj Finserv Ltd's board has approved pursuing re-insurance business through a subsidiary, subject to IRDAI and other authorities' approval.

Bajaj Finserv Ltd's board meeting outcome for the quarter ended 30 June 2026 includes approval of unaudited standalone and consolidated financial results, issue of equity shares to Bajaj Finserv ESOP Trust, and approval for pursuing re-insurance business.

Ishan Dyes and Chemicals Ltd has commenced activities for the production of four new high-value sulphur-based products at its Sulphuric Acid Unit, expected to be commercially launched within the next three months.

Fischer Medical Ventures Ltd's wholly owned subsidiary, Time Medical International Ventures (India) Pvt Ltd, has partnered with Parul Sevashram Hospital to install its revolutionary DRIS–iMRI Medharanya Suite, an AI-enabled next-generation portable intraoperative MRI system.

Mahan Industries Ltd has launched a new digital lending platform called 'Credit Mines' which enables customers to avail personal loans and other credit products in a fully digital, paperless manner.

Share India Securities Ltd has announced its Q1 FY 2027 earnings, with standalone revenue increasing by 28% YoY to Rs. 349 crores and profit after tax growing by 32% to Rs. 90.85 crore. Consolidated revenue increased by 31% YoY to Rs. 448 crores, with consolidated PAT rising by 48% to Rs. 124.41 crore.

Mahindra & Mahindra Ltd has announced its unaudited consolidated and standalone financial results for the quarter ended 30th June 2026, showing a total income from operations of Rs. 58,187.57 crore and a profit for the period of Rs. 5,454.54 crore.

Lupin Ltd has announced the US FDA approval and launch of Sugammadex Injection in the US market.

Spandana Sphoorty Financial Ltd's Q1 FY27 earnings conference call transcript reveals a good quarter with AUM growth of 11% to INR4,887 crores, new member addition of 61%, and annualized credit cost at 2.1%. The company collected INR51 crores in the 90-plus pool and garnered INR545 crores in sanctions under the credit guarantee scheme. PAT was INR12 crores, up from INR5 crores in the March '26 quarter. The company is focusing on growth in Tamil Nadu and Maharashtra, and is piloting an individual loan product in 8 branches in Madhya Pradesh.

Anlon Healthcare Limited has announced its unaudited Financial Results for Q1FY27, reporting a 163.02% year-on-year growth in consolidated Total Income to ₹87.62 Crore, 150.14% growth in EBITDA to ₹15.65 Crore, and 133.13% growth in Profit After Tax to ₹8.28 Crore. The company has strengthened its integrated pharmaceutical platform through strategic acquisitions, expanded its product portfolio, and improved operational synergies.

EMS Ltd has received a Letter of Intent (LOI) from Delhi Jal Board for a sewerage work contract with an estimated order value of Rs. 15,828.57 lakhs.